Precigen to participate in the jmp securities hematology and oncology summit

Germantown, md. , nov. 29, 2023 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that helen sabzevari, phd, president and ceo of precigen, will participate in a fireside chat at the jmp securities hematology and oncology summit on wednesday, december 6, 2023 at 3:00 pm et.
PGEN Ratings Summary
PGEN Quant Ranking